Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

How does antiangiogenic therapy affect brain tumor response to radiation?

Nature Clinical Practice Oncology volume 2, pages 232–233 (2005)Cite this article

boxed-textWinkler F et al. (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6: 553–563

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Mauceri HJ et al. (1998) Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 394: 287–291

    Article  CAS  PubMed  Google Scholar 

  2. Gorski DH et al. (1999) Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 59: 3374–3378

    CAS  PubMed  Google Scholar 

  3. Wachsberger P et al. (2003) Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. Clin Cancer Res 9: 1957–1971

    CAS  PubMed  Google Scholar 

  4. Tse V et al. (2003) The temporal-spatial expression of VEGF, angiopoietins-1 and 2, and Tie-2 during tumor angiogenesis and their functional correlation with tumor neovascular architecture. Neurol Res 25: 729–738

    Article  CAS  PubMed  Google Scholar 

  5. Siemeister G et al. (1999) Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway. Cancer Res 59: 3185–3191

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. the Daniel K Ludwig Professor and Chairman of Radiation Oncology, and Head of Molecular Oncology, the University of Chicago, IL, USA

    Ralph R Weichselbaum

Authors
  1. Ralph R Weichselbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ralph R Weichselbaum.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Glossary

VEGFR

Vascular endothelial growth factor receptor; receptor for a soluble factor that stimulates vascular permeability and growth of blood vessels

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weichselbaum, R. How does antiangiogenic therapy affect brain tumor response to radiation?. Nat Rev Clin Oncol 2, 232–233 (2005). https://doi.org/10.1038/ncponc0177

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0177

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing